Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based cancer therapy. Helper T cells act as the immune system’s coordinators, helping ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

Cutaneous squamous-cell carcinoma (SCC) is primarily caused by oncogenesis mediated by ultraviolet radiation, and β-human papillomavirus (β-HPV) is believed to be a mere facilitator that is ...

T-cell engagers are antibody-based therapeutics that can reprogram T cells for antigen-specific elimination of target cells. The modality has remained a big draw for Big Pharma, with Eli Lilly penning ...

Human-accelerated regions (HARs) are sections of the human genome that have accumulated an unusually high level of mutations as humans split away from chimpanzees. Given their rapid evolution, some ...

Human “bodyoids” could reduce animal testing, improve drug development, and alleviate organ shortages. Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for ...